Welcome: Guest | Site Use Options | Register | Login |

Amplyx Pharma Nabs $1.5M

Awardee Story Amplyx Pharma Nabs $1.5M
Date: Apr 08, 2010

Source: xConomy ( click here to go to the source)

Amplyx Pharmaceuticals, a San Diego-based drug developer, has raised an initial round of $1.5 million in financing. The investors included Golden Seeds, Life Science Angels, and Tech Coast Angels. The company, led by CEO Elaine Heron, is developing technology to improve existing drugs by controlling their concentration and time they hit their targets, according to a statement. The company noted that Golden Seeds is a national angel investment network that invests in women-led companies.

News Bureau

Your OPPORTUNITY to upload into this extensively used SBIR-STTR Tracking system

  • Published articles about YOUR SBIR-involved firm
  • Press releases for pick-up by other sources
  • Professional papers; White papers; relevant Business materials

It is a rare issue of the major Business Press - WSJ; New York Times; Washington Post - and regional equivalents; magazines of similar importance - The Economist, Fortune, Forbes etc - and now a wealth of electronic communications and daily news feeds that does not include reference to, or articles about, one/more SBIR-STTR Awardees. With the focus usually on what the firm is about - their technical achievement or business emphasis - it is an unusual coverage that even mentions their SBIR involvement. An integral part of the extensive range of data we continuously assembled in our system on all SBIR-STTR involved firms includes this type of press coverage.  Much that we gather includes firms no longer SBIR involved or still in business, nor now eligible. ...more

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920